...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Are hERG channel blockers also phospholipidosis inducers?
【24h】

Are hERG channel blockers also phospholipidosis inducers?

机译:hERG通道阻滞剂是否也是磷脂诱导剂?

获取原文
获取原文并翻译 | 示例
           

摘要

Both pharmacophore models of the human ether-à-go-go-related gene (hERG) channel blockers and phospholipidosis (PLD) inducers contain a hydrophobic moiety and a hydrophilic motif/positively charged center, so it is interesting to investigate the overlap between the ligand chemical spaces of both targets. We have assayed over 4000 non-redundant drug-like compounds for both their hERG inhibitory activity and PLD inducing potential in a quantitative high throughput screening (qHTS) format. Seventy-seven percent of PLD inducing compounds identified from the screening were also found to be hERG channel blockers, and 96.9% of the dually active compounds were positively charged. Among the 48 compounds that induced PLD without inhibiting hERG channel, 24 compounds (50.0%) carried steroidal structures. According to our results, hERG channel blockers and PLD inducers share a large chemical space. In addition, a positively charged hERG channel blocker will most likely induce PLD, while a steroid PLD inducer is less likely a hERG channel blocker.
机译:人源于去的相关基因(hERG)通道阻滞剂和磷脂(PLD)诱导剂的药效基团模型均包含疏水部分和亲水基序/带正电的中心,因此研究两者之间的重叠非常有趣。两个靶的配体化学空间。我们已经通过定量高通量筛选(qHTS)格式对4000多种非冗余类药物化合物的hERG抑制活性和PLD诱导潜力进行了分析。从筛选中鉴定出的77%的PLD诱导化合物也是hERG通道阻滞剂,并且96.9%的双重活性化合物带正电。在诱导PLD而不抑制hERG通道的48种化合物中,有24种(50.0%)具有类固醇结构。根据我们的结果,hERG通道阻滞剂和PLD诱导剂共享较大的化学空间。另外,带正电的hERG通道阻滞剂最有可能诱导PLD,而类固醇PLD诱导剂不太可能是hERG通道阻滞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号